On August 8, the National Health and Health Committee issued a notice on the continuation of replanting related expenses for rabies vaccinators in Changchun Changsheng Company: in order to safeguard the legitimate rights and interests of vaccinators, the relevant units in the continuation of breeding and follow-up observation of rabies vaccine No fees may be charged to the vaccinator.
For those who have been vaccinated within three months of vaccination, they should be self-observed within three months, if there are abnormalities and contact with relevant units;
For those who have been over one year old, there is no discomfort. In principle, there is no need to observe, but if there are abnormal situations, you need to contact the relevant units.
Rabies is an acute infectious disease caused by rabies virus. It is common in humans and animals. It is more common in carnivores such as dogs, wolves and cats. Many people are infected by bites of sick animals. The clinical manifestations are characteristic of fear of water, fear of wind, pharyngeal spasm, progressive spasm and so on. Because the symptoms of fear of water are more prominent, the disease is also known as hydrophobia.
The rabies virus belongs to the genus Rhabdovirus of the Rhabdoviridae, a single-stranded RNA virus, and the animals spread the virus by biting each other. Rabies in China are mainly transmitted by dogs, and dogs can become asymptomatic carriers, so dogs with "healthy" surfaces are very harmful to human health. There is still no effective treatment for rabies. The mortality rate after rabies is almost 100%. Patients usually die of respiratory or circulatory failure within 3 to 6 days. Therefore, preventive measures should be strengthened.
On August 9, Changchun Changsheng Biology issued an announcement that the shares held by Gao Junfang and Zhang Youkui, the responsible persons of Changsheng Biological, have been frozen by the judiciary. According to the announcement, Gao Junfang holds 176,234,880 shares of Changsheng Bio, Zhang Youkui. It holds 6,579,434 shares of Changsheng Bio, holding a total of 182,814,314 shares.
Case-related investigations are still in progress.
ZHEJIANG SHENDASIAO MEDICAL INSTRUMENT CO.,LTD. , https://www.shendasiaomed.com